Table 2.
Surgical and management outcomes of the study population.
| Characteristic | Total (n = 83) | Group A—2020 (n = 41) |
Group B—2019 (n = 42) |
p Value |
|---|---|---|---|---|
| Waiting time for surgery | 47.8 ± 12.6 | 49.1 ± 12.6 | 46.4 ± 11.6 | 0.38 |
| Type of surgery | <0.001 | |||
| BCS | 61 (73.5%) | 32 (78.0%) | 29 (69.0%) | |
| Mastectomy alone | 10 (12.0%) | 9 (22.0%) | 1 (2.4%) | |
| Mastectomy + IR | 12 (14.5%) | 0 (0%) | 12 (28.6%) | |
| Sentinel node biopsy | 64 (77.1%) | 32 (78.0%) | 32 (76.2%) | 0.84 |
| Regional nerve blocks | 39 (47.0%) | 1 (2.4%) | 38 (90.5%) | <0.001 |
| Hospital stay | 2.0 ± 1.7 | 1.5 ± 1.02 | 2.5 ± 2.0 | 0.008 |
| Waiting time for postoperative oncological consultation | 24.0 ± 4.6 | 24.9 ± 4.6 | 23.1 ± 4.5 | 0.74 |
| Waiting time for chemotherapy | 44.5 ± 8.5 | 42.8 ± 10.1 | 45.4 ± 8.0 | 0.58 |
| Waiting time for radiotherapy consultation | 26.0 ± 3.4 | 26.1 ± 3.5 | 25.9 ± 3.4 | 0.77 |
BCS: Breast Conserving Surgery; IR: Immediate Reconstruction.